Testing effectiveness (Phase 2)Study completedNCT03694275
What this trial is testing
A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)
Who this might be right for
15q Duplication SyndromeCDKL5 Deficiency Disease
Takeda 20